Literature DB >> 12058097

HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration.

K H L Ching1, S K Westaway, J Gitschier, J J Higgins, S J Hayflick.   

Abstract

HARP (hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration) is a rare syndrome with many clinical similarities to pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome). Despite these common features, lipoprotein abnormalities have not been reported in PKAN. After the recent discovery of the genetic defect in PKAN, we report a homozygous nonsense mutation in exon 5 of the PANK2 gene that creates a stop codon at amino acid 371 (R371X) in the original HARP patient. This finding establishes that HARP is part of the PKAN disease spectrum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12058097     DOI: 10.1212/wnl.58.11.1673

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Dietary rescue of fumble--a Drosophila model for pantothenate-kinase-associated neurodegeneration.

Authors:  Y Yang; Z Wu; Y M Kuo; B Zhou
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes.

Authors:  Manju A Kurian; Susan J Hayflick
Journal:  Int Rev Neurobiol       Date:  2013       Impact factor: 3.230

Review 3.  Neurodegeneration with brain iron accumulation.

Authors:  Allison Gregory; Susan J Hayflick
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

4.  Panthotenate Kinase-Associated Neurodegeneration Has a Founder Mutation (c.215_216insa) in Indian Agrawal Patients.

Authors:  Vrajesh Udani; Soma Das; Rahul Chhabria
Journal:  Mov Disord Clin Pract       Date:  2016-04-05

5.  Altered neuronal mitochondrial coenzyme A synthesis in neurodegeneration with brain iron accumulation caused by abnormal processing, stability, and catalytic activity of mutant pantothenate kinase 2.

Authors:  Paul T Kotzbauer; Adam C Truax; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

6.  A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: evidence for a founder effect.

Authors:  P Rump; H H Lemmink; C C Verschuuren-Bemelmans; P M Grootscholten; J M Fock; S J Hayflick; S K Westaway; Y J Vos; A J van Essen
Journal:  Neurogenetics       Date:  2005-10-21       Impact factor: 2.660

Review 7.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation.

Authors:  A Gregory; B J Polster; S J Hayflick
Journal:  J Med Genet       Date:  2008-11-03       Impact factor: 6.318

8.  Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration.

Authors:  Sarah Williams; Allison Gregory; Penelope Hogarth; Susan J Hayflick; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2013-07-01       Impact factor: 4.797

Review 9.  Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration.

Authors:  Neha Sami; Vijay Kumar; Asimul Islam; Sher Ali; Faizan Ahmad; Imtaiyaz Hassan
Journal:  Mol Neurobiol       Date:  2016-08-20       Impact factor: 5.590

Review 10.  Movement Disorders and Hematologic Diseases.

Authors:  Roshni Abee Patel; Deborah A Hall; Sheila Eichenseer; Meagan Bailey
Journal:  Mov Disord Clin Pract       Date:  2020-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.